82.79
  Price0.16%   -0.1400
 
Sep-24-21 08:27AM Pharma Stock Roundup: PFE Booster Jab Gets FDA Nod, JNJ's New Data on COVID-19 ShotZacks Investment Research
Sep-23-21 09:15AM Incyte (INCY) Jakafi Wins FDA Approval for Chronic GVHDZacks Investment Research
Sep-22-21 10:35AM Green Hygienics Holdings To Raise $100M Via Green Bond OfferingBenzinga
07:34AM The Zacks Analyst Blog Highlights: Facebook, Walmart, Novartis, PayPal and Advanced Micro DevicesZacks Investment Research
Sep-21-21 01:23AM Top Research Reports for Facebook, Walmart & NovartisZacks Investment Research
08:20AM The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot DataBenzinga
Sep-20-21 02:29AM Why Did Deutsche Bank Downgrade This Big Pharma Stock?Benzinga
Sep-19-21 09:46AM The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The SpotlightBenzinga
08:30AM Chinese Internet Stocks: One Step Forward, Two Steps BackSeeking Alpha
Sep-16-21 11:03AM BeiGene (BGNE) Scores Third FDA Nod for Brukinsa in LymphomaZacks Investment Research
11:02AM Are You a Value Investor? This 1 Stock Could Be the Perfect PickZacks Investment Research
Sep-15-21 09:40AM 3 Top Chinese Stocks to Watch in SeptemberThe Motley Fool
Sep-14-21 03:36AM CureVac Shares Fall After Cutting COVID-19 Vaccine Production PlansBenzinga
10:31AM Celldex (CLDX) Initiates Subcutaneous Skin Disorder Drug StudyZacks Investment Research
Sep-13-21 02:40AM Why Regenxbio Stock Is Way Up TodayThe Motley Fool
11:35AM BeiGene's (BGNE) BLA for Tislelizumab in ESCC Accepted by FDAZacks Investment Research
Sep-10-21 02:49AM Shareholder Meetings, Conferences Ramp Up Ahead Of Q3 Earnings SeasonInvesting.com
Sep-09-21 12:37PM 3 Red-Hot Healthcare Stocks to Buy in SeptemberThe Motley Fool
Sep-02-21 09:17AM FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug LabelsZacks Investment Research
Aug-30-21 11:02AM Global Blood (GBT) Thrives on Oxbryta, Overdependence a WoeZacks Investment Research
Aug-27-21 04:51AM Top Analyst Reports for Pfizer, AT&T & IntuitZacks Investment Research
07:35AM The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology CollaborationBenzinga
Aug-27-21 07:19AM Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster DataZacks Investment Research
Aug-25-21 11:22AM Regeneron's (REGN) Wet AMD Study on High Dose Eylea Meets GoalZacks Investment Research
07:30AM The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's DrugBenzinga
Aug-24-21 11:57AM Novartis (NVS) Kymriah Misses Primary Endpoint in NHL StudyZacks Investment Research
08:09AM The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing DealBenzinga
Aug-21-21 07:00AM Could Veeva Systems Stock Help You Retire a Millionaire?The Motley Fool
Aug-20-21 10:27AM Bristol Myers (BMY) CAR T Cell Therapy Abecma Approved by ECZacks Investment Research
08:23AM Pharma Stock Roundup: FDA Nod for MRK, PFE Products & New Use of LLY, GSK DrugsZacks Investment Research
Aug-13-21 09:54AM Pharma Stock Roundup: FDA Nod for SNY's Pompe Drug & New Use of MRK's KeytrudaZacks Investment Research
06:27AM FDA authorizes booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patientsMarketWatch
Aug-12-21 02:04AM FDA to authorize booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patientsMarketWatch
01:50AM FDA to authorize booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patientsMarketWatch
Aug-12-21 10:32AM FDA to authorize booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patientsMarketWatch
Aug-11-21 02:06AM WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19Benzinga
Aug-09-21 11:52AM Mirati (MRTX) Stock Dips on Wider-Than-Expected Q2 LossZacks Investment Research
Aug-07-21 10:02AM Here Are the Winners of Cowen's Big Pharma R&D ShowdownThe Motley Fool
Aug-06-21 11:46AM Acceleron (XLRN) Q2 Loss Wider Than Expected, Revenues MissZacks Investment Research
01:29AM Tracking Kahn Brothers Portfolio - Q2 2021 UpdateSeeking Alpha
Aug-05-21 10:15AM Ionis (IONS) Q2 Earnings & Revenues Fall Short of EstimatesZacks Investment Research
Aug-04-21 11:58AM Alnylam's (ALNY) Q2 Earnings Miss Estimates, 2021 Guidance UpZacks Investment Research
10:39AM Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMNZacks Investment Research
Aug-04-21 09:16AM Why This 1 Momentum Stock Could Be a Great Addition to Your PortfolioZacks Investment Research
Aug-03-21 12:43PM Incyte (INCY) Q2 Earnings & Sales Beat on Solid Jakafi GrowthZacks Investment Research
11:05AM Hot Biotech Stocks To Watch After Sanofi’s Acquisition Of Translate BioPennyStocks
Aug-03-21 07:55AM The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics BusinessBenzinga
Aug-02-21 12:33PM Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's ViolaBenzinga
Jul-30-21 03:49AM Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The BiopharmaBenzinga
01:57AM Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2021 UpdateSeeking Alpha
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines to enhance health outcomes for patients and health-care providers. This segment also commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, pain, and respiratory; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as intraocular lenses to treat cataracts and refractive errors; viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery; and contact lenses, as well as contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers. Novartis AG has collaboration agreements with Xencor; QIAGEN N.V.; Surface Oncology; Intellia Therapeutics; Caribou Biosciences; Bristol-Myers Squibb; IBM Watson Health; Amgen; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Cap:    |  Volume (24h):